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Abstract:
 Psychoactive substances – chemical compounds which can alter a person’s mood, thoughts, and behaviors – 
may be liable to misuse and cause addiction. Internationally, many strategies have been implemented in order to limit 
the supply and demand of illegal substances, with a wide variation at the country level. Thailand is an upper-middle 
income country in Southeast Asia. Since 2015, Thai authorities and policymakers have instituted many changes to 
the legal controls on illegal drugs. The aim of this review was to summarise the history of drug control and regulation 
in Thailand, focusing on opioids (including Kratom), methamphetamines and cannabis, and the outcome of recent 
strategies. Recent measures towards decriminalising substance use disorders are also discussed.
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Thailand’s legal acts on drugs or illegal sub-
stances 
 Some psychoactive substances are addictive1 
and widely used without prescription. Though different 
strategies to limit illegal substance use have been seen 
at the international level2,3, each country enacts its own 
strategies to tackle this problem. This article aims to illus-
trate the history of drug regulation in Thailand using specific 
strategies from ancient times to the present era.
Ayutthaya and early Rattanakosin: the opium 
control
 Dating back to the reign of King Authong (the first 
king of Ayutthaya4) in 1360, the first formal legal document 
on opium in Thailand’s history banned the trade and use 
of opium and instituted fines and custodial punishments 
for lawbreakers. The acknowledgment of the harmful 
effects of opium use during that era was clearly evidenced 
by launching this opium regulation (Table 1). In the Ratta-
nakosin period, the prohibition continued during the reign 
of King Rama I, and there were further and more severe 
punishments during the reigns of King Rama II and King 
Rama III. In 1839, an epidemic of opium use was believed 
to be due to Chinese merchants who became addicted 
to opium while selling opium from India to Chinese people 
on behalf of the British. In response, King Rama III ordered 
a restricted operation to control and eradicate the problem 
at the time when the Chinese secret society (i.e., Ung-Yee) 
took control of criminal activity, including opium trading. 
 A new strategy to control opium use was intro-
duced during the reign of King Rama IV (1851–1868).5 
He judged that the goal of eradication was not proving 
successful. He decreed that only Chinese people were 
permitted to use and trade opium and levied a high tax. 
This resulted in opium trading being ranked as the fifth 
highest revenue to the country at that time. In Thailand (as 
elsewhere) in 1958, it remained lawful to possess opium 
for trading but possession for consumption was prohibited. 
However, the revolutionary council subsequently decided 
to completely prohibit the use and trade of opium. The 
death sentence could be applied to people trading opium 
and the council closed opium houses, then treatment and 
rehabilitation of people with opium addiction was promoted.
Late Rattanakosin: the development of laws 
and regulations and the rise of methamphe-
tamines
 The Narcotics Control Board of Thailand was 
founded in 1961, at the same time as the first Single 
Convention on Narcotic Drugs was issued. In 19766 the 
Board’s name was changed to the Office of Narcotics 
Control Board (ONCB) with a mandate to tackle heroin 
and opium. Subsequently, the Thai government decided 
to eradicate opium cultivation with American assistance 
provided by its special military service. Thus, help was 
provided to the hill tribe villagers, who made their living 
cropping opium, by replacing the illegal opium cultivation 
with other commercial plants that were judged to be legally, 
socially, and medically safer.7 At that time, the epidemics 
of opium and heroin appeared to subside, with the exception 
of regions in the northern provinces where heroin and 
opium remained problematic, although not at the level of an 
epidemic. 
 In the meantime, in contrast with the decline of 
opium cultivation8, other drugs such as methamphetamines 
emerged as serious problems in Thailand, as well as other 
southeast Asian countries. Since then the context of drug 
problems in Thailand has changed considerably. There 
are complex reasons for these changes, including the 
impact of policy, behavioral changes of drug traders, shifting 
attitudes and behaviors among drug users (especially 
new young adults and adolescents). 
 In 1979, the Narcotics Act was issued, classifying 
heroin as a Schedule I drug and prohibiting all use. Later, 
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the government observed the increased prevalence of 
ya-ma or ya-khayan (i.e., pharmaceutical products 
containing methamphetamines) causing psychosis. At 
the time, these drugs were popular among truck drivers 
and those who wanted to stay awake at night, such as 
college students, and were associated with increased 
rates of risky behaviors.9 Therefore, in 1996, the government 
changed the name of ya-ma (horse pill) or ya-khayan 
(diligent pill) to ya-ba (crazy pill), and also changed the 
class of the drug to Schedule I.9 In part, it would appear 
that this action was taken to warn people of the serious 
psychiatric effects, such as going crazy, of using ya-ba. 
However at the time, ya-ba/ya-ma became more popular 
among illegal drug users as the prevalence of opioid use 
fell. It is not known whether the current epidemic of ya-ba 
is due, at least in part, to the indirect advertisement 
caused by moving the class of the drug to Schedule I. 
However, it is also important to note that the relative cost 
of heroin in the illicit market was much higher compared 
to methamphetamines. Consequently, it was regulated by 
economic accessibility, while the price for methamphe-
tamines or ya-ba remained considerably cheaper than 
opioids, though much higher than the cost of the actual 
manufacturing process. Taken together, ya-ba may have 
become more popular than opioids and replaced the 
prevalence of opioids because of the lower price 
(economic accessibility) and the unintentional status 
gained from the policy change.
 The effects of the above measures were difficult to 
see directly because there was no database tracking the 
prevalence of drug consumption among the teenage and 
adult populations. In response, a survey by an ONCB-
funded academic network from universities with expertise 
in substance abuse and addiction was developed to 
estimate the number of people using drugs in the country. 
The Thailand Substance Abuse Academic Network in 
2001 reported that 7.8% of the Thai population had used 
ya-ba at least once in their lifetime.10 This placed Thailand, 
at that time, at the top of the methamphetamine-use 
countries in the world. 
Table 1 Timeline of drug regulation in Thailand from ancient times to the modern era
Period of time Importance Summary
Ayutthaya and early 
Rattanakosin (1360s-1960s)
The opium control -Ban on trade and use of opium and instituted fines and custodial 
  punishments.




The development of law 
regulation and the rise of 
methamphetamine
-The initiation of The Narcotics Control Board in Thailand to tackle 
  heroin and opium.
-The decline of opium cultivation by replacing opium with other 
  economic plants.
-The epidemic of methamphetamine (ya-ba) in contrast with the 
  decline of heroin use.
Modern era and trend 
toward future (from 2000s 
to present)
War on drugs and the 
new strategies for drug 
regulation
-War on drugs and its adverse effects such as violence, murder and 
  insecurity.
-The voluntary treatment of drug users, decriminalisation and legali-
  sation of medical use of drugs following international trend.
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Modern era: war on drugs and the new 
strategies for drug regulation
 In 2003, the country declared a war on drugs to 
tackle the problem, focusing on recruiting drug users to 
seek compulsory treatment in addition to destroying the 
routes of drug suppliers as summarised in the Table 1.11 
However, the implementation of this policy had a severe 
and unexpected adverse effect. After the war on drugs 
began, there were several extrajudicial killings of sus-
pected methamphetamine dealers in order to, claimed by 
police, avoid betrayal by their accomplices. This war on 
drugs had many serious effects, such as violence and 
instability, not only on the people who used drugs but also 
on their families and communities. Consequently, in 2015, 
Thailand’s military government issued an order to give 
the drug users caught by the police a chance to go free 
and receive treatment voluntarily. Currently, the new draft 
of the Narcotics Act is under review. It is predicted that 
the new draft will relax the punishments on drug users 
while permitting some substances to be used for medical 
purposes. The changes will comply with international 
guidelines that call for the people who use drugs not to be 
treated as criminals, but as people who require medical, 
psychological, and social help. For example, in 2016, the 
United Nations General Assembly Special Session on 
Drugs issued an agreement stating that decriminalisation 
is one of the measures necessary to solve the drug 
problem.
 Although control of methamphetamines has been 
the priority for policymakers, the trend of using addictive 
plants in Thailand has received increasing attention. 
Here, the debate has centered on comparing the benefits 
and costs in order to consider legalising, regulating, or
decriminalising the use of some addictive plants. For 
example, opium is a plant that is considered to cause 
more harm than good, especially due to its addictive 
effect and high risk of overdose/poisoning. Therefore, 
there has not been much debate on whether it should be 
controlled or forbidden from general use (with the excep-
tion of some medicines, such as tincture of opium, which 
has been used in some clinical addiction treatment settings 
in Thailand to aid in the detoxification of other opioid use).12
 
The future: the trend of legalisation and 
decriminalisation of cannabis and kratom 
 Cannabis is judged to be less addictive than 
opium, with a psychological rather than predominantly 
physical withdrawal syndrome.13 While the risk of increasing 
the propensity of primary psychotic disorders (including 
schizophrenia) is conclusive14, there is weaker evidence 
that cannabis affects some people because of risks (i.e., 
vulnerable genes), and there is also mixed evidence that 
cannabis is helpful for serious medical diseases.15 Another 
potential harmful effect of cannabis is impaired cognitive 
functioning16, especially judgment during intoxication that 
could increase the incidence of accidents in various situa-
tions. Although cannabis is the most commonly used illegal 
substance globally, due to the potential harm it can cause 
as mentioned above, the current trend for policymakers 
abroad (e.g. several states in the United States and some 
European countries) is to legalise its recreational use under 
controls; the name of this measure is called “regulation”. 
Alcohol and tobacco are good examples of the measure of 
“regulation”, which has been used to identify a substance 
as legal but under the control of a licensed retailer. It is 
proposed that  the sale and  consumption of cannabis take 
place  at bars and pubs under strict licensing conditions.17
 In the new draft of the Narcotics Act, there is poten-
tial to allow the use of cannabis only for medical use, but 
not for recreational use (The current law does not allow 
any use of cannabis in the country.) The impact of the 
change in policy of moving a drug down a scheduled 
class or having less control over the drug will need to be 
monitored. There is a chance of an increase in drug 
Kalayasiri R, et al.Regulation and Decriminalisation of Illegal Substances in Thailand
Journal of Health Science and Medical Research                            J Health Sci Med Res 2019;37(2):157-162161
use in the population due to a change in the attitude of 
the population toward seeing the drug as less harmful to 
oneself, family, or society. However, decriminalisation (i.e., 
do not charge criminally) of cannabis use could help with 
the attitude of people toward drug users, although such 
benefits may be difficult to measure concretely.
 There has been a long, ongoing debate about 
the legalisation (with control or regulation) and decrimi-
nalisation of Kratom (or mytragyna speciosa). It is worth 
noting that Kratom consumption in Thailand appears in 
2 forms: chewing the Kratom leaves or using the water 
extracted from boiling the leaves.18 Traditional use is by 
chewing the leaves. The Kratom water is usually mixed 
with other psychoactive substances, such as cough 
syrup, tramadol or codeine, and cola, and is known as 
the Kratom cocktail.19 In addition, there are rumors that 
some people who use the Kratom cocktail have also put 
fluorescent or mosquito incense into the mixture.
 According to the 2016 survey, Kratom has the 
highest incidence of misuse in Thailand with 16.6% of the 
population having used it within the past year.20 Kratom 
has been more difficult than cannabis for Thailand’s policy-
makers in making a decision about legalisation because 
Kratom leaf chewing has long been popular in the everyday 
life of people in some areas. An epidemiological study in 
a community setting did not report evidence of Kratom 
being harmful, and it suggested that drug users believed it 
may even be beneficial to their health, such as helping to 
treat diabetes mellitus.18 However, hospitals in the epidemic 
regions frequently see patients who use Kratom having 
psychotic episodes or becoming addicted to the drug with 
more than just mild withdrawal symptoms. There was also 
a report from the Thailand Poison Center of several cases 
of Kratom-induced seizures and withdrawal symptoms.21 
Consequently, Kratom has not been declared safe by 
the authorities in Thailand. Nevertheless, traditional Thai 
medicine claims that Kratom can be used in treatment 
recipes for the symptoms of fatigue. However, the side 
effects of psychotic symptoms and addictive/withdrawal 
symptoms may be prime concerns for the drug’s effects 
on health. The prevalence of psychotic symptoms and 
addiction among traditional leaf chewing users warrants 
further investigation. Some chemical structures in Kratom 
have been registered for a patent by a group of scientists 
from Japan, it is believed, for use in pain treatments, but 
again, the safety of this use needs to be studied further. 
 No final decision about revising the law has been 
made yet. If the result is to retain the current illegal status 
of the drug, then a debate concerning the penalty (i.e., 
criminalise the people who are caught or fine and send 
them for treatment) should be considered seriously. It 
needs to be decided whether it is reasonable to charge 
someone with a crime when an addicted person cannot 
control his or her own behavior, especially as drug abuse/
dependence is perceived to be a disease. However, 
this does not apply to separate criminal acts that should 
still be prosecuted, such as producing and selling drugs, 
especially those that are harmful to others. 
Conclusion
 As elsewhere, Thailand has a long history of addic-
tion problems. Many measures have been advanced 
with varying success. The current drug situation in Thai-
land is a live issue. Drug legalisation (with regulation) 
and decriminalisation is a subject of debate across 
society. Such a debate should include appraisals of health 
risks and potential medical benefits, while recognising 
the complexity of the topic across other spheres. 
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